Pharmaguy

Pharmaguy

×  

Follow This Show

If you liked this show, you should follow Pharmaguy.

Risk Mitigation and Its Impact on Pharma Marketing

  Broadcast in Business

Call in to speak with the host

(347) 996-5894

A conversation with Jeff Fetterman, President and CEO of ParagonRx, about developing a Risk Evaluation and Mitigation Strategy (REMS) that clinicians will consider useful and that would raise their intent to prescribe.
Tags:
pharmaceutical
marketing
ParagonRx
Drug Risk
REMS
h:755
s:696598
archived

Comments

 comments